Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02134535 · ClinicalTrials.gov registry record
Optimization of the ex Vivo Challenge
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 73
- Enrollment target
NCT02134535: Completed study, sponsored by University of Pittsburgh.
NCT02134535 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02134535 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The overall purpose of this research study is to collect vaginal and cervical biopsies from healthy HIV negative participants. These samples will enable investigators to optimize laboratory methods and explore implementation challenges associated with the ex vivo challenge model. The first objective is to assess which HIV virus is best for use in the model. The second objective is to determine the best endpoint for the assay. The primary aim of this study is to collect an adequate number of cervical and vaginal biopsies to support the optimization of an ex vivo challenge model. This ex vivo challenge model has been and will continue to be used in topical microbicide clinical trials to predict the efficacy of candidate drugs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-03 |
What the finished NCT02134535 record still lists
NCT02134535 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02134535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02134535 about?
NCT02134535 is a clinical study titled "Optimization of the ex Vivo Challenge". The overall purpose of this research study is to collect vaginal and cervical biopsies from healthy HIV negative participants. These samples will enable investigators to optimize laboratory methods and explore implementation challenges associated with the ex vivo challenge model. The first objective...
What is the current status of trial NCT02134535?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-05. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02134535?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia